oxazoles has been researched along with Angiogenesis, Pathologic in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JY; Lim, W; Park, H; Park, S; Song, G | 1 |
| Chen, C; Dai, M; Li, H; Wang, D; Wang, W; Wu, L | 1 |
| Hou, MC; Hsieh, YC; Huang, CC; Huang, SF; Huang, YH; Lee, KC; Li, TH; Lin, HC; Liu, RS; Tsai, HC; Yang, YY | 1 |
| Han, F; Li, J; Liu, M; Qi, X; Wang, P; Zhang, Q; Zhang, W | 1 |
| Biersack, B; Dietrich, A; Effenberger, K; Knauer, S; Mueller, T; Schobert, R | 1 |
| Chen, XH; Deng, ZT; Feng, T; Geng, MY; Li, J; Li, YX; Qi, X; Song, CL; Wang, P | 1 |
| Amano, H; Hayashi, I; Inukai, M; Kamata, M; Kitasato, H; Majima, M; Yoshida, S; Yoshimura, H | 1 |
| Enomoto, M; Gonda, T; Higuchi, T; Kobayashi, H; Sugihara, K; Uetake, H | 1 |
| Asakage, M; Hori, N; Kaisaki, S; Kawai, K; Kitayama, J; Nagawa, H; Okaji, Y; Sunami, E; Takahashi, K; Tsuno, NH; Watanabe, T; Yazawa, K | 1 |
| Esumi, H; Ikeda, D; Kawada, M; Kunimoto, S; Masuda, T; Ohba, S; Osono, M | 1 |
| Ali, MA; Choy, H; Habib, AA; Saha, D | 1 |
| Arneric, SP; Iadecola, C; Reis, DJ | 1 |
12 other study(ies) available for oxazoles and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Developmental toxicity and angiogenic defects of etoxazole exposed zebrafish (Danio rerio) larvae.
Topics: Animals; Apoptosis; Cell Cycle; Embryo, Nonmammalian; Embryonic Development; Environmental Exposure; Humans; Larva; Neovascularization, Pathologic; Oxazoles; Reactive Oxygen Species; Toxicity Tests; Water Pollutants, Chemical; Zebrafish | 2019 |
PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents; Benzoates; Bezafibrate; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase Inhibitors; Cytochrome P450 Family 2; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eicosanoids; Indomethacin; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Metastasis; Neovascularization, Pathologic; Oxazoles; PPAR alpha; Pyrimidines; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension.
Topics: Animals; Caco-2 Cells; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Neovascularization, Pathologic; Oxazoles; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Thiophenes | 2018 |
CA-1H, a novel oxazole bearing analogue of combretastatin A-4, disrupts the tumor vasculatures and inhibits the tumor growth via inhibiting tubulin polymerization.
Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cytoskeleton; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Necrosis; Neovascularization, Pathologic; Neovascularization, Physiologic; Oxazoles; Polymerization; Stilbenes; Tubulin; Xenograft Model Antitumor Assays | 2016 |
4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Chick Embryo; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Imidazoles; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Germ Cell and Embryonal; Neovascularization, Pathologic; Neovascularization, Physiologic; Oxazoles; Stilbenes; Structure-Activity Relationship; Testicular Neoplasms; Transplantation, Heterologous; Tubulin Modulators | 2010 |
Effects of the novel vascular targeting agent MDS-11P on tumor vascularity and its antitumor activity.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Endothelial Cells; Epirubicin; Humans; Male; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Neovascularization, Pathologic; Organophosphates; Oxazoles; Prodrugs; Rats; Rats, Sprague-Dawley; Tubulin | 2011 |
COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo.
Topics: Animals; Antibodies, Blocking; Aspirin; Benzenesulfonates; Carcinoma, Lewis Lung; Cyclooxygenase Inhibitors; Disease Models, Animal; Endothelial Growth Factors; Intercellular Signaling Peptides and Proteins; Isoxazoles; Lymphokines; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Nitrobenzenes; Oxazoles; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma 180; Sulfonamides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model study.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Colorectal Neoplasms; Cyclooxygenase 2; Enzyme Inhibitors; Isoenzymes; Logistic Models; Lung Neoplasms; Male; Microcirculation; Microscopy, Electron, Scanning; Neovascularization, Pathologic; Oxazoles; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Rats; Rats, Inbred F344 | 2004 |
Selective inhibition of cyclooxygenase (COX)-2 inhibits endothelial cell proliferation by induction of cell cycle arrest.
Topics: Apoptosis; Benzenesulfonates; Cell Adhesion; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Extracellular Matrix; G1 Phase; Humans; Isoenzymes; Matrix Metalloproteinase 2; Membrane Proteins; Neovascularization, Pathologic; Oxazoles; Prostaglandin-Endoperoxide Synthases; Umbilical Veins | 2005 |
Antitumor effect of kigamicin D on mouse tumor models.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Doxorubicin; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Oxazoles; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2006 |
SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor.
Topics: Angiogenesis Inhibitors; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Endothelial Cells; Glioblastoma; Humans; Neovascularization, Pathologic; Oxazoles; Protein Kinase Inhibitors; Thiazoles; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2007 |
Local and remote microvascular changes in excitotoxin-induced focal brain lesions.
Topics: Animals; Brain; Ibotenic Acid; Male; Neovascularization, Pathologic; Neurotoxins; Oxazoles; Rats; Rats, Inbred Strains | 1989 |